Literature DB >> 6401767

Selective inhibition of follicle-stimulating hormone secretion by estradiol. Mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone.

J C Marshall, G D Case, T W Valk, K P Corley, S E Sauder, R P Kelch.   

Abstract

Prepubertal girls and gonadotropin-releasing hormone (GnRH)-deficient females secrete follicle-stimulating hormone (FSH) preferentially in response to intravenous GnRH. With continued pulsatile GnRH stimulation, FSH secretion is reduced when plasma estradiol (E2) is increasing. To delineate the mechanisms involved in these changing gonadotropin responses, e studied the effect of low dose (0.025 micrograms/kg) pulsatile injections of GnRH in females with varying degrees and/or duration of endogenous GnRH deficiency (idiopathic panhypopituitarism, PHP; isolated growth hormone deficiency, IGHD; isolated gonadotropin deficiency, IGD; and anorexia nervosa, AN; both at low body weight and after weight regain). In patients presumed to have the most severe GnRH deficiency (PHP), responses of both FSH and luteinizing hormone (LH) were small and delayed, and no increase in plasma estradiol occurred during the 5 d of GnRH injections. In patients previously exposed to prepubertal or adult levels of endogenous GnRH secretion (IGHD, IGD, AN at low body weight), a rapid initial FSH response occurred that subsequently declined when plasma estradiol rose to concentrations greater than 40-50 pg/ml. Prior therapy with estrogen (micronized estradiol, Estrace) abolished FSH responses but LH responses were only slightly impaired. The degree of FSH response was dependent upon the time of initiation of estrogen relative to the onset of GnRH injections. Administration of estrogen after the first GnRH injection inhibited gonadotropin responses, whereas later estrogen therapy (after 1 d of GnRH pulses) blunted the GnRH induced FSH secretion without significantly impairing the LH response. In weight-regained anorexic patients who had spontaneous pulsatile LH secretion and a mean basal plasma estradiol concentration of 53 +/- 15 pg/ml, administration of GnRH pulses did not change plasma LH and a minimal FSH response was seen. The data indicate that the pattern of gonadotropin responses to low dose GnRH injections depends upon the degree of previous exposure of the pituitary to endogenous GnRH. Furthermore, estradiol selectively inhibits FSH secretion by a direct action on the pituitary gland. This action of estradiol provides an explanation for the selective reduction in FSH responses to GnRH seen during pubertal maturation in girls and during the mid-follicular stage of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401767      PMCID: PMC436863          DOI: 10.1172/jci110765

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Stimulatory action of follice-stimulating hormone on estradiol-17 beta secretion by hypophysectomized rat ovaries in organ culture.

Authors:  Y S Moon; J H Dorrington; D T Armstrong
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

2.  Estradiol augmentation of pituitary responsiveness to gonadotropin-releasing hormone in women.

Authors:  R B Jaffe; W R Keye
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

3.  Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.

Authors:  B M Sherman; S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

4.  The absence of positive feedback between estrogen and luteinizing hormone in sexually immature girls.

Authors:  E O Reiter; H E Kulin; S M Hamwood
Journal:  Pediatr Res       Date:  1974-08       Impact factor: 3.756

5.  Radioimmunoassay of estradiol-17beta without chromatography.

Authors:  B G England; G D Niswender; A R Midgley
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

6.  Plasma levels of luteinizing hormone and of immunoreactive oestrogens (oestradiol) in anorexia nervosa: response to clomiphene citrate.

Authors:  P J Beumont; P J Carr; M G Gelder
Journal:  Psychol Med       Date:  1973-11       Impact factor: 7.723

7.  The significance of weight loss in the evaluation of pituitary response to LH-RH in women with secondary amenorrhea.

Authors:  M P Warren; R Jewelewicz; I Dyrenfurth; R Ans; S Khalaf; R L Vande Wiele
Journal:  J Clin Endocrinol Metab       Date:  1975-04       Impact factor: 5.958

8.  LH and FSH response to gonadotropin-releasing hormone in anorexia nervosa: Effect of nutritional rehabilitation.

Authors:  B M Sherman; K A Halmi; R Zamudio
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

9.  Serum LH and FSH responses to the repetitive administration of gonadotropin-releasing hormone in patients with idiopathic hypogonadotropic hypogonadism.

Authors:  J F Reitano; R Caminos-Torres; P J Snyder
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

10.  Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone.

Authors:  A R Midgley
Journal:  Endocrinology       Date:  1966-07       Impact factor: 4.736

View more
  9 in total

1.  Phytoestrogens enhance antioxidant enzymes after swimming exercise and modulate sex hormone plasma levels in female swimmers.

Authors:  Antonia Mestre-Alfaro; Miguel D Ferrer; Antoni Sureda; Pedro Tauler; Elisa Martínez; Maria M Bibiloni; Vicente Micol; Josep A Tur; Antoni Pons
Journal:  Eur J Appl Physiol       Date:  2011-02-18       Impact factor: 3.078

Review 2.  Maturation of sleep-wake gonadotrophin-releasing hormone secretion across puberty in girls: potential mechanisms and relevance to the pathogenesis of polycystic ovary syndrome.

Authors:  C R McCartney
Journal:  J Neuroendocrinol       Date:  2010-05-12       Impact factor: 3.627

3.  Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women.

Authors:  N D Shaw; S N Histed; S S Srouji; J Yang; H Lee; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2010-02-04       Impact factor: 5.958

Review 4.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

5.  Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation.

Authors:  Nelly Pitteloud; Apisadaporn Thambundit; Andrew A Dwyer; John L Falardeau; Lacey Plummer; Lisa M Caronia; Frances J Hayes; Hang Lee; Paul A Boepple; William F Crowley
Journal:  Neuroendocrinology       Date:  2009-10-15       Impact factor: 4.914

6.  Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.

Authors:  M G Forest
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

7.  Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome.

Authors:  Laura C Torchen; Ajay Kumar; Bhanu Kalra; Gopal Savjani; Ryan Sisk; Richard S Legro; Andrea Dunaif
Journal:  Fertil Steril       Date:  2016-04-01       Impact factor: 7.329

8.  Effect of estradiol on penile erection: a cross-sectional study.

Authors:  Zhi-He Xu; Xin-He Xu; Dong Pan; Tong-Yan Liu; Ming-Zhen Yuan; Shan Jiang; Yong Guan; Sheng-Tian Zhao
Journal:  Transl Androl Urol       Date:  2019-12

Review 9.  The role of estradiol in male reproductive function.

Authors:  Michael Schulster; Aaron M Bernie; Ranjith Ramasamy
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.